Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

WHO approves China's Sinopharm vaccine for emergency use

By Bo Leung in London | chinadaily.com.cn | Updated: 2021-05-07 23:30
Share
Share - WeChat

The World Health Organization announced on Friday it will give emergency use authorization to the COVID-19 vaccine manufactured by China's Sinopharm.

The greenlight for the Sinopharm vaccine to be rolled out globally could pave the way for millions of doses to reach needy countries and boost WHO-backed efforts such as the COVAX initiative, which is a global effort aimed at ensuring access in poorer nations to novel coronavirus vaccines.

The WHO program has already distributed over 54 million doses of COVID-19 vaccines.

The move marks the first time any Chinese-made vaccine has received emergency authorization from the WHO.

During a media briefing, the head of the WHO, Tedros Adhanom Ghebreyesus,?said: "WHO gave Emergency Use Listing to Sinopharm Beijing's COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality."

He added: "This expands the list of COVID-19 vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine."

The Sinopharm vaccine joins a list of WHO approved vaccines, in addition to those made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna.

"The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk," said Mariangela Simao, WHO assistant-director general for Access to Health Products. "We urge the manufacturer to participate in the COVAX Facility and contribute to the goal of more equitable vaccine distribution."

The WHO has recommended the jab for people aged 18 to 59 years, in a two-dose schedule with a spacing of three to four weeks.

The organization said the vaccine efficacy for symptomatic and hospitalized disease was estimated to be 79 percent, all age groups combined.?

Experts say the Sinopharm vaccine is easy to store, making it "highly suitable for low-resource settings".

The WHO said it is also the first vaccine that will carry a vaccine vial monitor, a small sticker on the?vaccine vials?that change color as the?vaccine?is exposed to heat, letting health workers know whether the?vaccine?can be safely?used.

Arnaud Didierlaurent, a professor at the University of Geneva's medical school who chairs the advisory group, said it had requested additional studies from Sinopharm, and that there would be "continuous evaluation" of the vaccine and noted that work "does not stop after the listing".

The Sinopharm vaccine has already been authorized by many countries around the world, with some 65 million doses distributed.

Recipients of the vaccine include those in Latin America such as Brazil, Mexico and Chile as well as countries in Asia, including Indonesia, Malaysia and Thailand.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 2020亚洲欧美日韩在线观看| 久久精品午夜一区二区福利| 美女张开腿让男人桶的动态图| 国产精品国产免费无码专区不卡 | 国内精品久久久久影院一蜜桃| 久久久久亚洲AV无码专区体验| 欧美性巨大欧美| 免费日韩在线视频| 西西人体高清444rt·wang| 日韩精品无码人妻一区二区三区| 免费人妻精品一区二区三区| 韩国精品视频在线观看| 国产精品无码专区在线播放| xyx性爽欧美| 日本三级特黄在线观看| 亚洲一区无码中文字幕乱码| 野外做受又硬又粗又大视频| 国产精品自产拍高潮在线观看| 一本之道高清在线| 日本成a人片在线观看网址| 亚洲一区欧美日韩| 污网站在线免费看| 加勒比黑人在线| 蝌蚪网站免费观看| 国产曰批免费视频播放免费s| 97se亚洲国产综合自在线| 妲己丰满人熟妇大尺度人体艺| 久久久久成人精品免费播放动漫| 欧美zoozzooz性欧美| 亚洲毛片基地4455ww| 精品久久久久久中文字幕一区| 国产乡下三级全黄三级bd| 久久国产精品99精品国产987| 国产精品视频福利| aaaaaaa一级毛片| 思思99re热| 久久久久久久99精品免费观看 | 吃奶呻吟打开双腿做受动态图| 黄网站在线播放| 国产真实伦在线视频免费观看| 91精品欧美成人|